Literature DB >> 29409132

Leydig cell insufficiency in hypospermatogenesis: a paracrine effect of activin-inhibin signaling?

S J Winters1, J P Moore1, B J Clark1.   

Abstract

Clinical findings and a variety of experimental models indicate that Leydig cell dysfunction accompanies damage to the seminiferous tubules with increasing severity. Most studies support the idea that intratesticular signaling from the seminiferous tubules to Leydig cells regulates steroidogenesis, which is disrupted when hypospermatogenesis occurs. Sertoli cells seem to play a pivotal role in this process. In this review, we summarize relevant clinical and experimental observations and present evidence to support the hypothesis that testicular activin signaling and its regulation by testicular inhibin may link seminiferous tubular dysfunction to reduced testosterone biosynthesis.
© 2018 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  Leydig cell; activin; hypospermatogenesis; inhibin; testosterone

Mesh:

Substances:

Year:  2018        PMID: 29409132     DOI: 10.1111/andr.12459

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  5 in total

1.  Sertoli Cell Alterations in Peripubertal Varicocelized Rats: Evidence of Primary Damage on Spermatogenesis.

Authors:  André da Costa Vaz; Camila Cicconi Paccola; Talita Biude Mendes; Regina Elizabeth Lourenço Cabral; Joana Noguères Simas; Vanessa Vendramini; Sandra Maria Miraglia
Journal:  J Histochem Cytochem       Date:  2020-01-27       Impact factor: 2.479

Review 2.  An update on male infertility and intratesticular testosterone-insight into novel serum biomarkers.

Authors:  Karim Sidhom; Kapilan Panchendrabose; Uday Mann; Premal Patel
Journal:  Int J Impot Res       Date:  2022-01-06       Impact factor: 2.896

Review 3.  Some of the Factors Involved in Male Infertility: A Prospective Review.

Authors:  Emad Babakhanzadeh; Majid Nazari; Sina Ghasemifar; Ali Khodadadian
Journal:  Int J Gen Med       Date:  2020-02-05

4.  Homozygosity for a novel INHA mutation in two male siblings with hypospadias, primary hypogonadism, and high-normal testicular volume.

Authors:  Esra Arslan Ates; Mehmet Eltan; Bahadir Sahin; Busra Gurpinar Tosun; Tuba Seven Menevse; Bilgen Bilge Geckinli; Andy Greenfield; Serap Turan; Abdullah Bereket; Tulay Guran
Journal:  Eur J Endocrinol       Date:  2022-03-23       Impact factor: 6.664

5.  The first report on homozygous INHA inactivation in humans.

Authors:  Ilpo Huhtaniemi
Journal:  Eur J Endocrinol       Date:  2022-05-19       Impact factor: 6.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.